Andre Tomlin

Profile photo of Andre Tomlin
André Tomlin is an Information Scientist with 20 years experience working in evidence-based healthcare. He's worked in the NHS, for Oxford University and since 2002 as Managing Director of Minervation Ltd, a consultancy company who do clever digital stuff for charities, universities and the public sector. Most recently André has been the driving force behind the Mental Elf and the National Elf Service; an innovative digital platform that helps professionals keep up to date with simple, clear and engaging summaries of evidence-based research. André is a Trustee at the Centre for Mental Health and an Honorary Research Fellow at University College London Division of Psychiatry. He lives in Bristol, surrounded by dogs, elflings and lots of woodland!

Website

Follow me here –

  • Badge_support
  • Badge_stat
  • Badge_creative

Functional analysis may be a promising alternative treatment for challenging behaviour in dementia

shutterstock_64903231

Mood, memory and behaviour are all affected by dementia and it is not unusual for behaviour to become ‘challenging’. People with dementia may become agitated or aggressive and this can be extremely difficult and stressful for family members and carers. Challenging behaviour has traditionally been managed with antipsychotic drugs, despite the fact that they do [read the full story…]

We'll be back soon!

shutterstock_92228278

Unfortunately due to unforeseen circumstances the WELD blog will not be updated for a few days. Please bear with us.  We’ll be back soon with your week day evidence updates! Cheers, John and Andre WELD Blog Team

ADHD drugs do not increase the risk of serious cardiovascular events, but long-term effects remain unknown

shutterstock_28777657

A number of concerns have arisen over recent years about the safety of the various drugs used to treat ADHD (Attention Deficit Hyperactivity Disorder) in children and young adults. These central nervous system stimulants include methylphenidate, dexmethylphenidate, dextroamphetamines, amphetamine salts, atomoxetine and pemoline. Case reports have highlighted that sudden cardiac death can be brought on [read the full story…]

How to speak to your psychiatrist: are we ready for shared decision making in mental health?

shutterstock_10284523

There’s a lot of talk about ‘shared decision making’ in the NHS right now. Many mental health patients say that they do not feel that they are properly listened to or that their expertise is not valued in the consultation, but it’s clear that many health professionals are quite evangelical about working in partnership with [read the full story…]

Children who have lived in care homes are at greater risk of suicide

shutterstock_80627563

There is remarkably little research in this field. Epidemiological studies of suicidal behaviour in children and young people from the care system have previously come mainly from Scandinavia. A Swedish longitudinal national cohort study (ref 2) from last year concluded that every seventh girl (14%) who left long-term foster family care after age 17 was [read the full story…]

When is it appropriate to prescribe antipsychotics to treat the behavioural and psychological symptoms of dementia?

shutterstock_11551324

This topic has been well publicised in recent years and for good reason. We know that there is a huge disparity between the number of people with dementia who are prescribed antipsychotics (180,000 in England each year) and the number who may derive some benefit from the treatment (36,000). We also know that dangerous side [read the full story…]

No evidence for the use of aspirin, steroids or NSAIDs for the treatment of Alzheimer’s disease

shutterstock_16791472

Alzheimer’s disease affects 1-2% of people aged 65-70 and approximately 20% of those over 80 years. As our population ages, the condition is on the increase and it’s estimated that 2030, an estimated 7.7 million Americans aged 65 and older will have Alzheimer’s disease. We do not yet know exactly how and why Alzheimer’s disease [read the full story…]

Group parenting programmes help improve child conduct problems, parental mental health and parenting skills

shutterstock_24785992

Conduct problems in young children are common and costly, so there’s lots of interest in training programmes that can help parents and children cope better. This new review from the Cochrane Developmental, Psychosocial and Learning Problems Group assesses the effectiveness and cost-effectiveness of behavioural and cognitive-behavioural group-based parenting programmes for improving child conduct problems, parental [read the full story…]

Well-being knowledge bank launched by the Office for National Statistics

shutterstock_24127210

The Office for National Statistics is developing ways to measure national well-being. This work got underway in late 2010 with a consultation exercise that led to the publication of an initial report in July 2011. This has now been supplemented by a website that contains a range of publications. The aim is that these new [read the full story…]

No good quality research to guide the treatment of late-onset schizophrenia

shutterstock_919124

Late-onset schizophrenia is relatively common. Onset after the age of 40 years is reported in 23% of patients hospitalised with schizophrenia. The condition is different from early-onset schizophrenia on a number of counts, including the response to antipsychotic drugs. This Cochrane review set out to assess the effects of antipsychotic drugs for elderly people with [read the full story…]